Patent Assignment
Reel/Frame 069121/0647
Change of Name
Recorded: 2024-10-04
Pages: 4
Assignor
ONCONOVA THERAPEUTICS, INC.
Executed: 2024-04-01
Assignee
TRAWS PHARMA, INC.
12 PENNS TRAIL, NEWTOWN, PENNSYLVANIA, 18940
Covered Properties
(4)
Formulations with Enhanced Stability and Bioavailability for Administantion of (E)-2,6-Dialkoxystyryl 4-Substituted Benzylsulfones
Formulation of (E)-2,4,6-Trimethoxystyryl-3-[(Carboxymethyl)Amino]-4-Methoxybenzylsulphone with Enhanced Stability and Bioavailability
8-Cyclopentyl-7-Oxo-2-(4-Piperazin-1-Yl-Phenylamino)-7, 8-Dihydro-Pyrido [2,3-D]Pyrimidine-6-Carbonitrile and Uses Thereof in Treating Proliferative Disorders
Application:
17/292,953 →
Publication:
US 2022/0002293
Formulation of (E)-2,4,6-Trimethoxystyryl-3-[(Carboxymethyl)Amino]-4-Methoxybenzylsulphone with Enhanced Stability and Bioavailability
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 28, 2017
From: MANIAR, MANOJ
To: ONCONOVA THERAPEUTICS, INC.
Reel/Frame 043426/0008 →
Assignment of Assignor's Interest
Oct 11, 2019
From: MANIAR, MANOJ
To: ONCONOVA THERAPEUTICS, INC.
Reel/Frame 050715/0312 →
Assignment of Assignor's Interest
Dec 17, 2021
From: MANIAR, MANOJ; REN, CHEN; MALLIREDDIGARI, MURALIDHAR
To: ONCONOVA THERAPEUTICS, INC.
Reel/Frame 058422/0247 →
Assignment of Assignor's Interest
Oct 3, 2024
From: MANIAR, MANOJ
To: ONCONOVA THERAPEUTICS, INC.
Reel/Frame 069106/0402 →